Does GEFITINIB Cause Decreased appetite? 163 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 163 reports of Decreased appetite have been filed in association with GEFITINIB (Gefitinib). This represents 3.5% of all adverse event reports for GEFITINIB.
163
Reports of Decreased appetite with GEFITINIB
3.5%
of all GEFITINIB reports
44
Deaths
55
Hospitalizations
How Dangerous Is Decreased appetite From GEFITINIB?
Of the 163 reports, 44 (27.0%) resulted in death, 55 (33.7%) required hospitalization, and 12 (7.4%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for GEFITINIB.
What Other Side Effects Does GEFITINIB Cause?
Malignant neoplasm progression (1,651)
Drug resistance (1,228)
Death (590)
Diarrhoea (393)
Rash (318)
Metastases to central nervous system (306)
Acquired gene mutation (250)
Disease progression (244)
Drug ineffective (197)
Off label use (166)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which GEFITINIB Alternatives Have Lower Decreased appetite Risk?
GEFITINIB vs GELATIN
GEFITINIB vs GEMCITABINE
GEFITINIB vs GEMCITABINE\GEMCITABINE
GEFITINIB vs GEMFIBROZIL
GEFITINIB vs GEMTUZUMAB OZOGAMICIN